Valens Groworks Corp Stock price Canadian Securities Exchange

Equities

VGW

CA91913D1069

Pharmaceuticals

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Valens Groworks Corp -7.04% +162.25%
Dynamic Chart
The Valens Company Inc.(NasdaqCM:VLNS) dropped from NASDAQ Composite Index CI
SNDL Inc. completed the acquisition of remaining 91.9% stake in The Valens Company Inc.. CI
Valens Gets Final Court Order Approving Proposed Arrangement With SNDL MT
The Valens Co Obtains Final Court Order Approving Proposed Arrangement With SNDL MT
The Valens Company Obtains Final Court Order Approving Proposed Plan of Arrangement With SNDL MT
The Valens Company Granted Additional 180-Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule MT
North American Morning Briefing : Investors Wary -2- DJ
The Valens Co Brief: Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule MT
Valens Gets Additional 180-Day Period to Regain Nasdaq Compliance MT
The Valens Company Brief: Says Shareholders Vote in Favour of the Arrangement with SNDL MT
The Valens Company Brief: Both Institutional Shareholder Services and Glass Lewis & Co. Recommend Shareholders of Co Vote For Proposed Arrangement With SNDL Inc. MT
Earnings Flash (VLN) VALENS SEMICONDUCTOR Posts Q3 Revenue $23.1M, vs. Street Est of $22.7M MT
Earnings Flash (VLN) VALENS SEMICONDUCTOR Posts Q3 EPS $-0.02, vs. Street Est of $-0.08 MT
The Valens Company Inc. Secures Sales Licence for Greater Toronto Area Beverage Facility CI
The Valens Company Brief: Announcing Mailing and Filing of Circular for Special Meeting of Shareholders To Approve Arrangement With SNDL Inc. MT
More news
Managers TitleAgeSince
Chief Executive Officer 45 -
Director of Finance/CFO - 21-05-16
President - 19-05-31
Members of the board TitleAgeSince
Director/Board Member - 20-06-11
Chairman - 20-06-11
Director/Board Member - 18-09-03
More insiders
The Valens Company Inc. is a Canada-based company, which is engaged in the manufacturing of cannabinoid-based products. It operates through two segments: Canada and United States and International. Canada segment includes all business-to-business and business-to-consumer activity within Canada. This includes toll processing and co-packing, product sales, and analytical testing. United States and International segment include all activity related to the Green Roads CBD health and wellness manufacturing facility in Florida, United States. Its products are formulated for the recreational, health and wellness, and medical consumer segments and are offered across all cannabis product categories. It also manufactures, distributes, and sells a range of cannabidiol (CBD) products in the United States through its subsidiary Green Roads, Inc. (Green Roads), and distributes medicinal cannabis products to international markets through its subsidiary Valens Australia Pty Ltd (Valens Australia).
More about the company
  1. Stock
  2. Equities
  3. Stock The Valens Company Inc.
  4. Stock Valens Groworks Corp - Canadian Securities Exchange